The latest on HGH testing: Bud embarks on another "study"


HGH.jpgBud Selig says baseball’s new science adviser — Dr. Gary Green — is examining the human growth hormone blood
that the World Anti-Doping Agency (“WADA”) is peddling but he isn’t sure when
the study will be completed.

This is classic Bud: when he doesn’t want to deal with something he commissions another “study.”  I’m assuming that the HGH test study will be complete some time after the “What should we do with the Athletics” study, which has been pending for well over a year now despite the fact that everyone knows what the result will be. I’ve been critical of that particular bit of foot-dragging, but in the case of the HGH test I’m just fine with it.

Why? Because the WADA HGH test is basically useless, because WADA is a publicity and profit-seeking shakedown operation, and that because no one ever calls them on it, Selig is damned if he does and damned if he doesn’t.

As Murray Chass noted yesterday WADA’s head — Dr. Gary Wadler — is the go-to quote of choice whenever a steroids story pops up, selling his organization’s agenda and products as though he were an independent scholar or something. The effect of this is that anyone who exhibits opposition to WADA, even on legitimate grounds, has come to be seen by the media and the public as not being serious about combating PED use. And that’s even the case if the WADA product in question — an HGH blood test — is of dubious efficacy.

Bud Selig and baseball were late to the anti-PED party, but they’re pretty well-versed in it now. They know that WADA’s blood test has caught exactly one offender in several years, and even then it was because the authorities were tipped off about the guy using drugs beforehand. Because of that, they know that it’s probably a useless test that they’d never be able to sell to the players’ union.

But they also know that simply rejecting it out of hand would make them appear soft on PEDs and would lead to a bunch of articles — with critical quotes from Dr. Gary Wadler, natch — excoriating them. Articles that fail to note that the same man tut-tutting baseball is out to make a buck.

So what to do about it? Stall! Commission a study. Punt the issue for several months if not longer. And you know what? It’s the smart play.

Report: Athletics sign Trevor Cahill to one-year deal

Getty Images
1 Comment

Free agent right-hander Trevor Cahill reportedly has a one-year deal in place with the Athletics, according to’s Jane Lee. The exact terms have yet to be disclosed, and as the agreement is still pending a physical, it has not been formally announced by the club.

Cahill, 30, is coming off of a decent, albeit underwhelming year with the Padres and Royals. He kicked off the 2017 season with a 4-3 record in 11 starts for the Padres, then split his time between the rotation and bullpen after a midseason trade to the Royals. By the end of the year, the righty led the league with 16 wild pitches and had racked up a 4.93 ERA, 4.8 BB/9 and 9.3 SO/9 in 84 innings for the two teams.

The A’s found themselves in desperate need of rotation depth this week after Jharel Cotton announced he’d miss the 2018 season to undergo Tommy John surgery. Right now, the team is considering some combination of Andrew Triggs, Daniel Gossett, Daniel Mengden and Paul Blackburn for the back end of the rotation — a mix that seems unlikely to change in the last two weeks before Opening Day, as Lee points out that Cahill won’t be ready to shoulder a full workload by then. Instead, he’s expected to begin the year in the bullpen and work his way up to a starting role, where the A’s hope he’ll replicate the All-Star numbers he produced with them back in 2010.